Aditxt to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 26 2025
0mins
Source: Yahoo Finance
Aditxt's Presentation: Aditxt, Inc. CEO Amro Albanna will present at Wall Street Reporter's NEXT SUPER STOCK livestream event on June 26, 2025, discussing the company's innovation acceleration model and updates on its programs in autoimmunity and cancer detection, as well as the pending acquisition of Evofem Biosciences.
Acquisition Details: The proposed acquisition of Evofem is targeted for completion in the second half of 2025, contingent upon shareholder approval and Aditxt securing approximately $17 million in funding to fulfill its obligations, including payments to Evofem's senior secured noteholder.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like ADTX with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on ADTX
About ADTX
Aditxt, Inc. is a social innovation platform dedicated to accelerating promising health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. It also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aditxt Inc. (ADTX) Completes Reverse Split, Shares Surge Over 20%
- Stock Price Surge: Aditxt Inc. saw its stock price rise over 20% to $1.44 in premarket trading on Wednesday, indicating strong market confidence in its immune modulation technologies and future growth prospects.
- Reverse Stock Split: The company executed a 1-for-113 reverse stock split on January 11, 2026, aimed at maintaining compliance with Nasdaq's minimum bid price requirements, thereby enhancing its market appeal and compliance status.
- Special Shareholder Meeting: Aditxt has scheduled a virtual special shareholder meeting for January 30, 2026, where shareholders will vote on significant capital and governance proposals, including the authorization of convertible preferred stock, which could profoundly impact the company's future financing capabilities.
- Employee Stock Purchase Plan: The meeting will propose the adoption of a 2025 Employee Stock Purchase Plan reserving 200,000 shares, designed to incentivize employees and strengthen the internal shareholder structure, thereby enhancing employee engagement and productivity.
Continue Reading
GameStop Corp (GME) CEO Ryan Cohen Buys 500,000 Shares, Stock Rises 2.6%
- CEO Stock Purchase: GameStop CEO Ryan Cohen disclosed the purchase of 500,000 shares at an average price of approximately $21.12 per share in an SEC filing, which not only boosts market confidence but may also enhance investor expectations regarding the company's future growth.
- Stock Price Surge: Following this announcement, GameStop's stock rose 2.6% to $21.65 in pre-market trading, indicating a positive market reaction to the company's strategic direction, potentially attracting more investor interest.
- Market Movements: Pineapple Financial saw a dramatic increase of 175.2% to $2.67 in pre-market trading, reflecting market recognition of its first-quarter gross billings of $4.1 million and revenue of $0.7 million, showcasing its future growth potential.
- Other Stock Performances: Anteris Technologies announced plans for a $200 million public offering, resulting in a 26.4% increase in its stock price to $7.27, indicating a positive market response to its capital expansion plans, which may provide funding support for future growth.
Continue Reading